Novartis AG is 165.5x more valuable than AGIOS PHARMACEUTICALS, INC. by market capitalization ($283.13 B vs $1.71 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | AGIO | NVS |
|---|---|---|
| Market cap | $1.71 B | $283.13 B |
| US-listed rank | #2223 | #47 |
| Revenue (latest FY) | $54.03M | - |
| Net income (latest FY) | -$413.00M | - |
| Net margin | -764.4% | - |
| SEC filings | 1,268 | 947 |
Novartis AG is 165.5x more valuable than AGIOS PHARMACEUTICALS, INC. by market capitalization ($283.13 B vs $1.71 B).
Full pages: AGIOS PHARMACEUTICALS, INC. and Novartis AG, or browse the full rankings.